Profile
Kirby S.
Black was the founder of AuraZyme Pharmaceuticals, Inc. founded in 2000, where he held the title of Chief Operating Officer.
Dr. Black's current job is as a Professor at Kennesaw State University since 2005.
Dr. Black's former jobs include being the President & Chief Executive Officer at EPIX Pharmaceuticals, Inc. from 1990 to 1993 and Director at Advanced Tissue Sciences, Inc. in 1994.
Dr. Black was also a Board of Director at Neurobiology Foundation from 2012 to 2018 and Managing Partner at Epic BioVentures LLC from 2010 to 2018.
Dr. Black's education includes an undergraduate degree from the University of California, Los Angeles in 1976 and a doctorate degree from the University of California, Irvine in 1990.
Kirby Black active positions
| Companies | Position | Start |
|---|---|---|
Kennesaw State University
Kennesaw State University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 06/06/2011 |
Former positions of Kirby Black
| Companies | Position | End |
|---|---|---|
Epic BioVentures LLC
Epic BioVentures LLC Investment ManagersFinance Epic BioVentures focuses on investments in early- to mid-stage medical device, biotechnology, diagnostic and pharmaceutical companies. The firm targets companies with: (1) modest capital requirements (2) a preferred exit strategy by acquisition or merger with a corporate partner and (3) exit timing of 3 three years, often prior to pivotal clinical trials or market launch. The Epic BioVentures I Fund invests in early to mid-stage medical technology companies with high anticipated return potential. Epic BioVentures mitigates risk through investments in a well-diversified portfolio. They seek to invest in portfolio companies with the strong potential to exit within 3 years of their investment | Private Equity Investor | 01/09/2018 |
AuraZyme Pharmaceuticals, Inc.
AuraZyme Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops light-activated drug delivery systems for conditions like cancer, heart attack, stroke and blood clots | Founder | 31/01/2004 |
LifeModeler, Inc.
LifeModeler, Inc. Packaged SoftwareTechnology Services Manufactures human simulation software solutions | Corporate Officer/Principal | 31/01/1996 |
Advanced Tissue Sciences, Inc.
Advanced Tissue Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services Develops human-based tissue products for therapeutic applications | Corporate Officer/Principal | 31/01/1994 |
Training of Kirby Black
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 10 |
|---|---|
Advanced Tissue Sciences, Inc.
Advanced Tissue Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services Develops human-based tissue products for therapeutic applications | Commercial Services |
Artivion, Inc.
Artivion, Inc. Medical SpecialtiesHealth Technology Provides cryopreserved human tissue for vascular transplant applications | Health Technology |
EPIX Pharmaceuticals, Inc.
EPIX Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Develops pharmaceuticals | Health Technology |
LifeModeler, Inc.
LifeModeler, Inc. Packaged SoftwareTechnology Services Manufactures human simulation software solutions | Technology Services |
University of California, Los Angeles
University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kennesaw State University
Kennesaw State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Berkeley
University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Irvine
University of California, Irvine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AuraZyme Pharmaceuticals, Inc.
AuraZyme Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops light-activated drug delivery systems for conditions like cancer, heart attack, stroke and blood clots | Health Technology |
Epic BioVentures LLC
Epic BioVentures LLC Investment ManagersFinance Epic BioVentures focuses on investments in early- to mid-stage medical device, biotechnology, diagnostic and pharmaceutical companies. The firm targets companies with: (1) modest capital requirements (2) a preferred exit strategy by acquisition or merger with a corporate partner and (3) exit timing of 3 three years, often prior to pivotal clinical trials or market launch. The Epic BioVentures I Fund invests in early to mid-stage medical technology companies with high anticipated return potential. Epic BioVentures mitigates risk through investments in a well-diversified portfolio. They seek to invest in portfolio companies with the strong potential to exit within 3 years of their investment | Finance |
- Stock Market
- Insiders
- Kirby Black
















